Related Experiment Video
Updated: Jan 8, 2026
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Associations of LDL and HDL cholesterol with lung function decline and risk of airflow obstruction in a
Jaeeun Yoo1, Chin Kook Rhee2, Yong Suk Jo2
1Department of Laboratory Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Abstract:
Dyslipidemia may affect pulmonary function through systemic inflammation and metabolic pathways; however, longitudinal evidence remains limited. This study examined the associations of baseline low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels with subsequent rates of lung function decline and the incidence of airflow obstruction in a community-based observational cohort, Korean Genome and Epidemiology Study (KoGES). We analyzed 7381 participants without baseline airflow obstruction. LDL cholesterol was categorized as ≤ 130 mg/dL (LDLlow), 130-160 mg/dL (LDLmedium), and > 160 mg/dL (LDLhigh), while HDL cholesterol was classified as ≤ 50 mg/dL (HDLlow) and > 50 mg/dL (HDLhigh). Annual changes in FEV₁ and FVC were estimated using linear mixed-effects models, and Cox proportional hazards models were applied to assess the risk of incident airflow obstruction. Compared with the LDLlow group, participants in the LDLhigh group had a slower annual decline in FEV₁ (- 37.21 mL/year, 95% CI: -39.00 to - 35.43) versus (- 40.39 mL/year, 95% CI: -40.94 to - 39.84) and FVC (- 30.06 mL/year, 95% CI: -32.18 to - 27.94) versus (- 35.78 mL/year, 95% CI: -36.43 to - 35.13), respectively (both p < 0.001). Higher LDL levels were significantly associated with a lower risk of incident airflow obstruction (adjusted HR: 0.71, 95% CI: 0.54-0.92). In contrast, higher HDL levels were associated with a faster FEV₁ decline (- 41.34 mL/year, 95% CI: -42.44 to - 40.24) compared with HDLlow (- 37.84 mL/year, 95% CI -38.46 to - 37.22, p < 0.001), but not with FVC decline or incident airflow obstruction. Higher baseline LDL cholesterol levels were associated with a slower decline in lung function and a lower risk of developing airflow obstruction, whereas higher HDL cholesterol levels were associated with an accelerated decline in FEV₁. These findings highlight complex, potentially bidirectional relationships between lipid metabolism and respiratory outcomes, warranting further mechanistic research. Importantly, these associations should not be interpreted as implying that high LDL is beneficial for general health.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:26Atherosclerosis III: Management
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...